BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17363735)

  • 1. Limiting {gamma}c expression differentially affects signaling via the interleukin (IL)-7 and IL-15 receptors.
    Smyth CM; Ginn SL; Deakin CT; Logan GJ; Alexander IE
    Blood; 2007 Jul; 110(1):91-8. PubMed ID: 17363735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A partial deficiency of interleukin-7R alpha is sufficient to abrogate T-cell development and cause severe combined immunodeficiency.
    Roifman CM; Zhang J; Chitayat D; Sharfe N
    Blood; 2000 Oct; 96(8):2803-7. PubMed ID: 11023514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel IL2RG Mutation Causes Leaky TLOWB+NK+ SCID With Nodular Regenerative Hyperplasia and Normal IL-15 STAT5 Phosphorylation.
    Neves JF; Martins C; Cordeiro AI; Neves C; Plagnol V; Curtis J; Fabre M; Bibi S; Borrego LM; Moshous D; Nejentsev S; Gilmour K
    J Pediatr Hematol Oncol; 2019 May; 41(4):328-333. PubMed ID: 29939941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional interaction of common gamma-chain and growth hormone receptor signaling apparatus.
    Adriani M; Garbi C; Amodio G; Russo I; Giovannini M; Amorosi S; Matrecano E; Cosentini E; Candotti F; Pignata C
    J Immunol; 2006 Nov; 177(10):6889-95. PubMed ID: 17082603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel splice-site mutation in the common gamma chain (gammac) gene IL2RG results in X-linked severe combined immunodeficiency with an atypical NK+ phenotype.
    Ginn SL; Smyth C; Wong M; Bennetts B; Rowe PB; Alexander IE
    Hum Mutat; 2004 May; 23(5):522-3. PubMed ID: 15108287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct interaction between Kit and the interleukin-7 receptor.
    Jahn T; Sindhu S; Gooch S; Seipel P; Lavori P; Leifheit E; Weinberg K
    Blood; 2007 Sep; 110(6):1840-7. PubMed ID: 17554063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications for gene therapy-limiting expression of IL-2R gamma c delineate differences in signaling thresholds required for lymphocyte development and maintenance.
    Orr SJ; Roessler S; Quigley L; Chan T; Ford JW; O'Connor GM; McVicar DW
    J Immunol; 2010 Aug; 185(3):1393-403. PubMed ID: 20592278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IL-2RG R328X nonsense mutation allows partial STAT-5 phosphorylation and defines a critical region involved in the leaky-SCID phenotype.
    Arcas-García A; Garcia-Prat M; Magallón-Lorenz M; Martín-Nalda A; Drechsel O; Ossowski S; Alonso L; Rivière JG; Soler-Palacín P; Colobran R; Sayós J; Martínez-Gallo M; Franco-Jarava C
    Clin Exp Immunol; 2020 Apr; 200(1):61-72. PubMed ID: 31799703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of gammac-dependent cytokines-mediated immunoregulation].
    Asao H
    Rinsho Byori; 2007 Jan; 55(1):51-8. PubMed ID: 17319491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4
    Seyfarth J; Mütze N; Antony Cruz J; Kummer S; Reinauer C; Mayatepek E; Meissner T; Jacobsen M
    Front Immunol; 2019; 10():820. PubMed ID: 31110501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with T⁺/low NK⁺ IL-2 receptor γ chain deficiency have differentially-impaired cytokine signaling resulting in severe combined immunodeficiency.
    Fuchs S; Rensing-Ehl A; Erlacher M; Vraetz T; Hartjes L; Janda A; Rizzi M; Lorenz MR; Gilmour K; de Saint-Basile G; Roifman CM; Cheuk S; Gennery A; Thrasher AJ; Fuchs I; Schwarz K; Speckmann C; Ehl S
    Eur J Immunol; 2014 Oct; 44(10):3129-40. PubMed ID: 25042067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy model of X-linked severe combined immunodeficiency using a modified foamy virus vector.
    Horino S; Uchiyama T; So T; Nagashima H; Sun SL; Sato M; Asao A; Haji Y; Sasahara Y; Candotti F; Tsuchiya S; Kure S; Sugamura K; Ishii N
    PLoS One; 2013; 8(8):e71594. PubMed ID: 23990961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel intronic splice site deletion of the IL-2 receptor common gamma chain results in expression of a dysfunctional protein and T-cell-positive X-linked Severe combined immunodeficiency.
    Gray PE; Logan GJ; Alexander IE; Poulton S; Roscioli T; Ziegler J
    Int J Immunogenet; 2015 Feb; 42(1):11-4. PubMed ID: 25443657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency.
    Puel A; Ziegler SF; Buckley RH; Leonard WJ
    Nat Genet; 1998 Dec; 20(4):394-7. PubMed ID: 9843216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial T cell defects and expanded CD56
    Cifaldi C; Cotugno N; Di Cesare S; Giliani S; Di Matteo G; Amodio D; Piano Mortari E; Chiriaco M; Buonsenso D; Zangari P; Pagliara D; Gaspari S; Carsetti R; Palma P; Finocchi A; Locatelli F; Rossi P; Doria M; Cancrini C
    J Leukoc Biol; 2020 Aug; 108(2):739-748. PubMed ID: 32392633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of aberrant CD8 T cell-restricted IL-7 signaling with a Janus kinase 3 defect-associated atypical severe combined immunodeficiency.
    Khanolkar A; Wilks JD; Liu G; Simpson BM; Caparelli EA; Kirschmann DA; Bergerson J; Fuleihan RL
    Immunol Res; 2020 Feb; 68(1):13-27. PubMed ID: 32215810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric γc cytokine receptors confer cytokine independent engraftment of human T lymphocytes.
    Hunter MR; Prosser ME; Mahadev V; Wang X; Aguilar B; Brown CE; Forman SJ; Jensen MC
    Mol Immunol; 2013 Nov; 56(1-2):1-11. PubMed ID: 23628622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T
    Stepensky P; Keller B; Shamriz O; von Spee-Mayer C; Friedmann D; Shadur B; Unger S; Fuchs S; NaserEddin A; Rumman N; Amro S; Molho Pessach V; Abuzaitoun O; Somech R; Elpeleg O; Ehl S; Warnatz K
    J Clin Immunol; 2018 May; 38(4):527-536. PubMed ID: 29948574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional role of interleukin-4 (IL-4) and IL-7 in the development of X-linked severe combined immunodeficiency.
    Kumaki S; Ishii N; Minegishi M; Tsuchiya S; Cosman D; Sugamura K; Konno T
    Blood; 1999 Jan; 93(2):607-12. PubMed ID: 9885222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency.
    De Ravin SS; Wu X; Moir S; Anaya-O'Brien S; Kwatemaa N; Littel P; Theobald N; Choi U; Su L; Marquesen M; Hilligoss D; Lee J; Buckner CM; Zarember KA; O'Connor G; McVicar D; Kuhns D; Throm RE; Zhou S; Notarangelo LD; Hanson IC; Cowan MJ; Kang E; Hadigan C; Meagher M; Gray JT; Sorrentino BP; Malech HL; Kardava L
    Sci Transl Med; 2016 Apr; 8(335):335ra57. PubMed ID: 27099176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.